Follow
Prostate Cancer
Prostate Cancer: is a cancer in a man's prostate, a small walnut-sized gland that produces seminal fluid. Some types of prostate cancer grow slowly, and other types are aggressive and require radiation, hormone therapy, surgery, chemotherapy, or other treatments.
-
AUG 30, 2017 | 10:00 AM
DATE: August 30, 2017TIME: 10:00am PT, 1:00pm ETRecent studies show that cancer cells can resist treatment by changing into a different cell type. Many treatments for specific cancers,...MAR 21, 2017 | 10:00 AM
DATE: March 21, 2017TIME: 10:00am PT, 1:00pm ETSponsored By: Prostate cancer is a complex disease with multiple tumors originating independent...Speaker: Nallasivam Palanisamy, PhD , Courtney Anderson, PhDSponsored By: Novus Biologicals a Bio-Techne BrandNOV 10, 2016 | 9:00 AM
DATE: November 10, 2016 TIME: 9:00am PT, Noon ET The CellSimple™ Cell Analyzer enables quick and easy research assays, including functional cell-based assays, cell-model...NOV 04, 2016 | 10:00 AM
DATE: November 4, 2016 TIME: 10:00am PT, 1:00pm ET How do you develop clinically relevant biomarkers? Systematic tumor profiling with multi-omics tools and rapid analytical...Speaker: Antonia Sepulveda, MD, PhD , Yang Yang, PhD , Tamara Lotan, MDSponsored By: Affymetrix, AffymetrixNOV 02, 2016 | 10:30 AM
Vitamin D3 supplementation can effectively remedy the current epidemic of vitamin D deficiency, especially within the African-American population and the elderly of any ethnicity. Racial disp...Speaker: Sebastiano Gattoni-Celli, MDOCT 06, 2016 | 6:00 AM
Over the past 6 years, a number of agents, all mechanistically different, have been approved with a statistically significant survival benefit as monotherapy for treatment of metastatic castr...Speaker: Raoul S. Concepcion, MD, FACSOCT 05, 2016 | 1:30 PM
...Speaker: Judd W Moul, MD, FACSOCT 05, 2016 | 9:00 AM
...AUG 11, 2016 | 11:00 AM
DATE: August 11, 2016 TIME: 11:00AM PST, 2:00PM ET, 7:00PM GMT The central dogma that forms the backbone of molecular biology is that DNA codes for RNA (transcription) which then c...JUL 20, 2016 | 8:00 AM
DATE: July 20thTIME: 8AM PT, 11AM ET, 5PM CESTTherapies like ipilimumab and nivolumab have shown the potential for approaches that direct the patient’s own immune system aga...JUN 15, 2016 | 8:00 AM
DATE: June 15, 2016TIME: 08:00AM PDT, 11:00AM EDT, 3:00PM GMT Positron Emission Tomography (PET) is a 3-dimensional, quantitative imaging technology that has robust clinical trans...JUN 09, 2016 | 9:00 AM
DATE: June 9, 2016 TIME: 9am Pacific time, 12pm Eastern time Complex cell and bead-based assays are simple and fast with the CellSimple™ Cell Analyzer. This instrument combine...Speaker: Wilfredo Garcia-Beltran , Jonah Riddell, PhDSponsored By: Cell Signaling Technology, Cell Signaling TechnologyMAY 12, 2016 | 7:30 AM
Circulating tumor cells (CTCs) is an emerging source used molecular cancer diagnostics. Through expression profiling of CTCs, it allows a deeper understanding about which metabolic pathways e...APR 07, 2016 | 6:00 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...APR 06, 2016 | 1:30 PM
Cancer remains the second leading cause of death in the United States. Most tumors arise from a myriad of genetic changes that dysregulate cell growth and prompt survival. Ident...Speaker: Hanna Rennert, PhD, F.A.C.M.GPresented at: Molecular Diagnostics Virtual Event Series 2016
FEB 24, 2016 | 1:00 PM
Precision medicine requires understanding the mechanistic basis of complex disorders, and to precisely manipulate these mechanisms to better human health. This is partly enabled by the recent...JAN 26, 2016 | 8:00 AM
DATE: January 26th, 2016 TIME: 8am pacific, 11am eastern PTEN gene loss occurs frequently in castration-resistant prostate cancer (CRPC) and may drive progression through activation of th...DEC 08, 2015 | 8:00 AM
Cancer-derived extracellular vesicles (EVs) play an important role in cancer progression and metastasis. They can be identified in biological fluids thus providing appealing candidates for no...Speaker: Dolores Di Vizio, MD, PHDPresented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life SciencesNOV 11, 2015 | 1:30 PM
This lecture will provide attendees with the knowledge and skills to bring on new clinical laboratory tests in clinical chemistry and molecular diagnostics. The lecture will provide a general...Speaker: Wieslaw Furmaga, MDNOV 11, 2015 | 6:00 AM
Cancer is complex, but recent findings are yielding a greater understanding of the disease. The tumor suppressor genes BRCA1 and BRCA2 are implicated in breast, ovarian, prostate, and other c...SEP 30, 2015 | 12:00 PM
This presentation discusses the advantages and disadvantages of robotic surgery. The initial goals for a robotic prostatectomy will be discussed as well as patient expectations and outcomes.&...Speaker: David Albala, MD , Herbert Lepor, MDSEP 30, 2015 | 10:30 AM
The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...Speaker: Rajan Gupta, MD , Thomas Polascik, MD , Stacy Loeb, MDSEP 30, 2015 | 9:00 AM
The burgeoning area of molecular risk assessment (gene expression profiling and/or proteomic tests) in the diagnosis and treatment of prostate cancer is rapidly illuminating how clinicians mi...SEP 30, 2015 | 7:30 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...
AUG 30, 2017 | 10:00 AM
DATE: August 30, 2017TIME: 10:00am PT, 1:00pm ETRecent studies show that cancer cells can resist treatment by changing into a different cell type. Many treatments for specific cancers,...
MAR 21, 2017 | 10:00 AM
DATE: March 21, 2017TIME: 10:00am PT, 1:00pm ETSponsored By: Prostate cancer is a complex disease with multiple tumors originating independent...
Speaker:
Nallasivam Palanisamy, PhD
, Courtney Anderson, PhD
Sponsored By: Novus Biologicals a Bio-Techne Brand
NOV 10, 2016 | 9:00 AM
DATE: November 10, 2016
TIME: 9:00am PT, Noon ET
The CellSimple™ Cell Analyzer enables quick and easy research assays, including functional cell-based assays, cell-model...
NOV 04, 2016 | 10:00 AM
DATE: November 4, 2016
TIME: 10:00am PT, 1:00pm ET
How do you develop clinically relevant biomarkers?
Systematic tumor profiling with multi-omics tools and rapid analytical...
Speaker:
Antonia Sepulveda, MD, PhD
, Yang Yang, PhD
, Tamara Lotan, MD
Sponsored By: Affymetrix,
Affymetrix
NOV 02, 2016 | 10:30 AM
Vitamin D3 supplementation can effectively remedy the current epidemic of vitamin D deficiency, especially within the African-American population and the elderly of any ethnicity. Racial disp...
Speaker:
Sebastiano Gattoni-Celli, MD
OCT 06, 2016 | 6:00 AM
Over the past 6 years, a number of agents, all mechanistically different, have been approved with a statistically significant survival benefit as monotherapy for treatment of metastatic castr...
Speaker:
Raoul S. Concepcion, MD, FACS
OCT 05, 2016 | 1:30 PM
...
Speaker:
Judd W Moul, MD, FACS
OCT 05, 2016 | 9:00 AM
...
AUG 11, 2016 | 11:00 AM
DATE: August 11, 2016
TIME: 11:00AM PST, 2:00PM ET, 7:00PM GMT
The central dogma that forms the backbone of molecular biology is that DNA codes for RNA (transcription) which then c...
JUL 20, 2016 | 8:00 AM
DATE: July 20thTIME: 8AM PT, 11AM ET, 5PM CESTTherapies like ipilimumab and nivolumab have shown the potential for approaches that direct the patient’s own immune system aga...
JUN 15, 2016 | 8:00 AM
DATE: June 15, 2016TIME: 08:00AM PDT, 11:00AM EDT, 3:00PM GMT Positron Emission Tomography (PET) is a 3-dimensional, quantitative imaging technology that has robust clinical trans...
JUN 09, 2016 | 9:00 AM
DATE: June 9, 2016
TIME: 9am Pacific time, 12pm Eastern time
Complex cell and bead-based assays are simple and fast with the CellSimple™ Cell Analyzer. This instrument combine...
Speaker:
Wilfredo Garcia-Beltran
, Jonah Riddell, PhD
Sponsored By: Cell Signaling Technology,
Cell Signaling Technology
MAY 12, 2016 | 7:30 AM
Circulating tumor cells (CTCs) is an emerging source used molecular cancer diagnostics. Through expression profiling of CTCs, it allows a deeper understanding about which metabolic pathways e...
APR 07, 2016 | 6:00 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...
APR 06, 2016 | 1:30 PM
Cancer remains the second leading cause of death in the United States. Most tumors arise from a myriad of genetic changes that dysregulate cell growth and prompt survival. Ident...
Speaker:
Hanna Rennert, PhD, F.A.C.M.G
Presented at: Molecular Diagnostics Virtual Event Series 2016
FEB 24, 2016 | 1:00 PM
Precision medicine requires understanding the mechanistic basis of complex disorders, and to precisely manipulate these mechanisms to better human health. This is partly enabled by the recent...
JAN 26, 2016 | 8:00 AM
DATE: January 26th, 2016
TIME: 8am pacific, 11am eastern
PTEN gene loss occurs frequently in castration-resistant prostate cancer (CRPC) and may drive progression through activation of th...
DEC 08, 2015 | 8:00 AM
Cancer-derived extracellular vesicles (EVs) play an important role in cancer progression and metastasis. They can be identified in biological fluids thus providing appealing candidates for no...
Speaker:
Dolores Di Vizio, MD, PHD
Presented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
NOV 11, 2015 | 1:30 PM
This lecture will provide attendees with the knowledge and skills to bring on new clinical laboratory tests in clinical chemistry and molecular diagnostics. The lecture will provide a general...
Speaker:
Wieslaw Furmaga, MD
NOV 11, 2015 | 6:00 AM
Cancer is complex, but recent findings are yielding a greater understanding of the disease. The tumor suppressor genes BRCA1 and BRCA2 are implicated in breast, ovarian, prostate, and other c...
SEP 30, 2015 | 12:00 PM
This presentation discusses the advantages and disadvantages of robotic surgery. The initial goals for a robotic prostatectomy will be discussed as well as patient expectations and outcomes.&...
Speaker:
David Albala, MD
, Herbert Lepor, MD
SEP 30, 2015 | 10:30 AM
The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...
Speaker:
Rajan Gupta, MD
, Thomas Polascik, MD
, Stacy Loeb, MD
SEP 30, 2015 | 9:00 AM
The burgeoning area of molecular risk assessment (gene expression profiling and/or proteomic tests) in the diagnosis and treatment of prostate cancer is rapidly illuminating how clinicians mi...
SEP 30, 2015 | 7:30 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...